Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Dec;104(4):928–932. doi: 10.1111/j.1476-5381.1991.tb12528.x

Attenuated responses to endothelin-1, KCl and CaCl2, but not noradrenaline, of aortae from rats with streptozotocin-induced diabetes mellitus.

D J Fulton 1, W C Hodgson 1, B W Sikorski 1, R G King 1
PMCID: PMC1908820  PMID: 1810603

Abstract

1. This study investigated the responsiveness to vasoconstrictor agents (including endothelin-1, ET-1) of aortic rings from rats with two-week streptozotocin (STZ, 60 mg kg-1, i.v.)-induced diabetes and vehicle-treated control rats. The basal tension was 10 g, which was estimated to be more physiological than the tension of 1-2 g that has been previously used for most studies of aortic rings from diabetic rats. 2. Maximum responses to ET-1 (0.13-18 nM), KCl (2-20 mM) or CaCl2 (10 microM-10 mM) were reduced in aortae from STZ-treated rats compared to those from control rats. Such reductions were still evident after removal of the endothelium. 3. Responses to noradrenaline (NA, 0.1 nM-26 microM) of aortae from STZ-treated rats were not significantly different from responses of aortae of control rats. 4. Removal of endothelium resulted in a significant reduction in the EC50 values for NA of rings from both STZ-treated rats (6.90 +/- 0.13 and 8.17 +/- 0.35 (-log M) with and without endothelium, respectively, n = 5) and control rats (6.90 +/- 0.15 and 8.37 +/- 0.44 (-log M) with and without endothelium, respectively, n = 5). 5. In calcium-free medium (with 1 mM EGTA), responses to NA and ET-1 were reduced compared with those in normal Krebs solution and maximum responses were less in rings from STZ-treated compared with control rats. 6. Indomethacin (5 microM) did not prevent the reduced maximum responsiveness to ET-1 in rings from STZ-treated rats compared with those from controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
928

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abebe W., Harris K. H., MacLeod K. M. Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol. 1990 Aug;16(2):239–248. doi: 10.1097/00005344-199008000-00010. [DOI] [PubMed] [Google Scholar]
  2. Angus J. A., Cocks T. M., Satoh K. Alpha 2-adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol. 1986 Aug;88(4):767–777. doi: 10.1111/j.1476-5381.1986.tb16249.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Colwell J. A., Halushka P. V., Sarji K. E., Lopes-Virella M. F., Sagel J. Vascular disease in diabetes: pathophysiological mechanisms and therapy. Arch Intern Med. 1979 Feb;139(2):225–230. [PubMed] [Google Scholar]
  4. Harris K. H., MacLeod K. M. Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur J Pharmacol. 1988 Aug 9;153(1):55–64. doi: 10.1016/0014-2999(88)90587-0. [DOI] [PubMed] [Google Scholar]
  5. Head R. J., Longhurst P. A., Panek R. L., Stitzel R. E. A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit. Br J Pharmacol. 1987 Jun;91(2):275–286. doi: 10.1111/j.1476-5381.1987.tb10282.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jeremy J. Y., Mikhailidis D. P., Dandona P. Differential inhibitory potencies of non-steroidal antiinflammatory drugs on smooth muscle prostanoid synthesis. Eur J Pharmacol. 1990 Jun 21;182(1):83–89. doi: 10.1016/0014-2999(90)90495-r. [DOI] [PubMed] [Google Scholar]
  7. Kamata K., Miyata N., Kasuya Y. Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats. J Pharmacol Exp Ther. 1989 Jun;249(3):890–894. [PubMed] [Google Scholar]
  8. Kiff R. J., Gardiner S. M., Compton A. M., Bennett T. Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol. 1991 Jun;103(2):1357–1362. doi: 10.1111/j.1476-5381.1991.tb09793.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kiff R. J., Gardiner S. M., Compton A. M., Bennett T. The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol. 1991 Jun;103(2):1321–1326. doi: 10.1111/j.1476-5381.1991.tb09787.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Law S. C., King R. G. Effects of ponalrestat on depressor responses to arachidonic acid in streptozotocin-diabetic rats. Gen Pharmacol. 1990;21(1):135–139. doi: 10.1016/0306-3623(90)90609-p. [DOI] [PubMed] [Google Scholar]
  11. Lüscher T. F., Yang Z. H., Diederich D., Bühler F. R. Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion. J Cardiovasc Pharmacol. 1989;14 (Suppl 6):S63–S69. [PubMed] [Google Scholar]
  12. Martin W., Furchgott R. F., Villani G. M., Jothianandan D. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1986 May;237(2):529–538. [PubMed] [Google Scholar]
  13. Miasiro N., Paiva A. C. Homologous desensitization of the effects of endothelin on rabbit aorta rings and on cultured rat aorta smooth muscle cells. Eur J Pharmacol. 1990 Apr 10;179(1-2):151–158. doi: 10.1016/0014-2999(90)90412-y. [DOI] [PubMed] [Google Scholar]
  14. Mulhern M., Docherty J. R. Effects of experimental diabetes on the responsiveness of rat aorta. Br J Pharmacol. 1989 Aug;97(4):1007–1012. doi: 10.1111/j.1476-5381.1989.tb12555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mulvany M. J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977 Jul;41(1):19–26. doi: 10.1161/01.res.41.1.19. [DOI] [PubMed] [Google Scholar]
  16. Owen M. P., Carrier G. O. Alteration in vascular smooth muscle sensitivity to vasoconstrictor agents by streptozotocin induced diabetes. Proc West Pharmacol Soc. 1979;22:363–366. [PubMed] [Google Scholar]
  17. Pfaffman M. A., Hilman R., Darby A. Contractile and relaxing activity of arterial smooth muscle from streptozotocin-diabetic rats. Res Commun Chem Pathol Pharmacol. 1980 Nov;30(2):283–299. [PubMed] [Google Scholar]
  18. Rakugi H., Nakamaru M., Tabuchi Y., Nagano M., Mikami H., Ogihara T. Endothelin stimulates the release of prostacyclin from rat mesenteric arteries. Biochem Biophys Res Commun. 1989 Apr 28;160(2):924–928. doi: 10.1016/0006-291x(89)92523-0. [DOI] [PubMed] [Google Scholar]
  19. Scarborough N. L., Carrier G. O. Increased alpha 2-adrenoreceptor mediated vascular contraction in diabetic rats. J Auton Pharmacol. 1983 Sep;3(3):177–183. doi: 10.1111/j.1474-8673.1983.tb00533.x. [DOI] [PubMed] [Google Scholar]
  20. Scarborough N. L., Carrier G. O. Nifedipine and alpha adrenoceptors in rat aorta. II. Role of extracellular calcium in enhanced alpha-2 adrenoceptor-mediated contraction in diabetes. J Pharmacol Exp Ther. 1984 Dec;231(3):603–609. [PubMed] [Google Scholar]
  21. Takahashi K., Ghatei M. A., Lam H. C., O'Halloran D. J., Bloom S. R. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 1990 May;33(5):306–310. doi: 10.1007/BF00403325. [DOI] [PubMed] [Google Scholar]
  22. Vane J. R., Anggård E. E., Botting R. M. Regulatory functions of the vascular endothelium. N Engl J Med. 1990 Jul 5;323(1):27–36. doi: 10.1056/NEJM199007053230106. [DOI] [PubMed] [Google Scholar]
  23. Vanhoutte P. M. Could the absence or malfunction of vascular endothelium precipitate the occurrence of vasospasm? J Mol Cell Cardiol. 1986 Jul;18(7):679–689. doi: 10.1016/s0022-2828(86)80940-3. [DOI] [PubMed] [Google Scholar]
  24. Wakabayashi I., Hatake K., Kimura N., Kakishita E., Nagai K. Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci. 1987 Feb 16;40(7):643–648. doi: 10.1016/0024-3205(87)90265-7. [DOI] [PubMed] [Google Scholar]
  25. Yamauchi T., Ohnaka K., Takayanagi R., Umeda F., Nawata H. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett. 1990 Jul 2;267(1):16–18. doi: 10.1016/0014-5793(90)80276-o. [DOI] [PubMed] [Google Scholar]
  26. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES